Agenda

Friday, March 8, 2019
Saturday, March 9, 2019
Friday, March 8, 2019
Session I – LAA Exclusion Anatomy and Imaging

Session 1 – LAA Exclusion Anatomy and Imaging –

Chair - Dr. Andrea Russo 

Discussants –  Dr. David Thaler and Dr. Walid Saliba

7:50 AM – 8:00 AM                   Understanding the LAA Anatomy – Relevance to Systemic Thromboembolization and Exclusion Techniques – Dr. Apostolos Tzikas

8:00 AM – 8:10 AM                   Pre and Intra-procedural TEE Imaging for Effective LAA Exclusion – Dr. Richard Wright

8:10 AM – 8:20 AM                    CT Imaging for LAA Exclusion – Pre and Post-Procedural Assessment – Dr. Jacqueline Saw

8:20 AM – 8:30 AM                   New Insights into Left Atrial Appendage Role in Atrial Arrhythmias Origin and Maintenance – Dr. Luigi Di Biase

8:30 AM – 8:40 AM                   Is the Thromboembolic Risk of Rheumatic AF Different Than Non-Valvular AF and Why? – Dr. Ajay Naik

8:40 AM – 8:50 AM                   Panel Discussion

Session II – Live Case 1

Chair – Dr. Andrea Natale                                         

Discussants – Dr. Jie Cheng and Dr. Claudio Tondo

8:50 AM – 9:30 AM                    Live Case

9:30 AM – 9:40 AM                    Here is How It All Started! – Dr. Michael Lesh

9:40 AM – 9:50 AM                    Post Implant Endothelialization - Mechanism and Predictors LAA Leaks Amongst Various LAA Exclusion Devices – Dr. Aloke Finn

9:50 AM – 10:00 AM                  Implications of Leaks on Systemic Thromboembolism and Long-Term OAC/APT After LAA Occlusion – Dr. Claudio Tondo

10:00 AM – 10:10 AM                Management of Endocardial Occluder Leaks – Dr. Amin Al-Ahmad

10:10 AM – 10:20 AM                Management of Epicardial Exclusion Device Leaks – Dr. Saibal Kar

10:20 AM – 10:30 AM                Panel Discussion

10:30 AM – 10:45 AM                Break

Session III – Live Case 2

Chair – Dr. David Holmes                                          

Discussants – Dr. Suneet Mittal and Dr. Krzysztof Bartus

10:45 AM – 10:55 AM                Dry Epicardial Access – Micro-Puncture, Epiep and More Practical Tips – Dr. Christopher Ellis

10:55 AM – 11:30 PM                Live Case

11:30 AM – 11:40 AM                Best Practices Managing Post-Procedural Pericardial Drain and Pericarditis – Colchicine, Steroids, Liposomal Bupivacaine and More – Dr. Abdi Raskeh

11:40 AM – 11:50 AM                How to Manage Acute and Subacute Pericardial Effusions After LAA Closure Device Placement? – Dr. Ken Huber

11:50 PM – 12:15 PM                Panel Discussion

12:15 PM – 1:00 PM                  Lunch Break

Session IV

Chair – Dr. Vivek Reddy                                            

Discussants – Dr. Basel Ramlawi and Dr. Claudio Tondo

1:00 PM – 1:10 PM                    Customizing Transseptal Access Based on Anatomy and Orientation of LAA – Dr. Moussa Mansour

1:10 PM – 1:50 PM                    Live Case

1:50 PM – 2:00 PM                    How Do You Manage Patients with Persistent LAA Filling Defect (Thrombus) More Anticoagulation or LAAO? - Dr. Jie Cheng

2:00 PM – 2:10 PM                    TEE is a Better Tool for Intraprocedural Management of LAA Closure Devices – Dr. Dr. Claudio Tondo

2:10 PM – 2:20 PM                    ICE is a Better Tool for Intraprocedural Management of LAA Closure Devices – Dr. Carlos Sanchez

2:20 PM – 2:30 PM                    Device Related Thrombus – Incidence, Mechanism and Implications to STE – Dr. Vivek Reddy

2:30 PM – 2:40 PM                    How to Manage DRT in Patients OAC Tolerant and Intolerant – Dr. Moussa Mansour

2:40 PM – 2:50 PM                    How to Manage LAAO Device Embolization – Dr. Jacqueline Saw

2:50 PM – 3:10 PM                    Panel Discussion

3:10 PM – 3:30 PM                    Break       

Session V

Chair – Dr. Saibal Kar                                

Discussants – Dr. Rakesh Abdi and Dr. Vijay Swarup

3:30 PM – 3:40 PM                    LAA Reservoir Function and Impact of Exclusion Versus Occlusion – Dr. Rakesh Gopinathannair

3:40 PM – 3:50 PM                    Impact of LAA Exclusion – ANP, RAAS, And LAA Homeostasis – Dr. Randall Lee

3:50 PM – 4:30 PM                    Live Case 

4:30 PM – 4:40 PM                    LAA Exclusion in Arrhythmia Rx – LAALA AF, Amaze and More – Dr. David Wilber

4:40 PM – 4:50 PM                    Epicardial LAA Exclusion for Poorly Controlled HTN in AF Patients. Where Does it Fit Along with Other Interventions? – Dr. Suneet Mittal

4:50 PM – 5:00 PM                    Economics of LAAO Program - The Organizational Perspective - Dr. Steven Manoukian

5:00 PM – 5:30 PM                    Panel Discussion

Saturday, March 9, 2019
Session VII

Chair – Dr. Dhanunjaya Lakkireddy            

Discussants – Dr. Luigi Di Biase and Dr. Andrea Natale

7:10 AM – 7:20 AM                   I am Not an Implanting Physician – Which Patient Do I Send for Consideration of LAA Closure – Dr. Richard Wright

7:20 AM – 7:30 AM                   How Do You Manage a Patient with GI Bleeding – A Gastroenterologist Perspective – Dr. Raj Vuppalanchi

7:30 AM – 7:40 AM                   Thank Zeus for LAA Closure –Dr. David Thaler

7:40 AM – 7:50 AM                   Sub-Clinical Atrial Fibrillation and Stroke Understanding the Connection – Dr. Andrea Russo

7:50 AM – 8:00 AM                   When Do you Consider LAAO in a Stroke/TIA/ICH Patient with AF? – Dr. Edip Gurol

8:00 AM – 8:10 AM                   Case-Based Learning – LAA Closure with WATCHMAN in a Patient with Multiple Strokes – Dr. Horst Sievert

8:10 AM – 8:30 AM                    In Non-Paroxysmal AF Patient LAA Endocardial Isolation with LAAO is a Better Strategy than LAA Epicardial Exclusion - Dr. Andrea Natale and Dr. Christopher Ellis

8:30 AM - 8:50 AM                     Panel Discussion

8:50 AM – 9:10 AM    Break

Session VIII

Chair – Dr. James Edgerton                       

Discussants – Dr. Jie Cheng and Dr. Moussa Mansour

9:10 AM – 9:20 AM                    Updates on Less Studied LAA Occlusion Devices – An Overview and Relevance (Includes Aegis/Occlutech/Prolipsis/Cardia/Acoredis and More – Dr. Horst Sievert

9:20 AM – 9:40 AM                    Debate: New Indications for LAA Closure: WATCHMAN/LAA Occluder Should be Done Along with AF Ablation in the Same Setting? Pro - Dr. Walid Saliba      Con - Dr. Moussa Mansour

9:40 AM – 9:50 AM                    Anatomic Considerations for AtriClip – Mini-Thoracotomy/Vats/Open Approach - Dr. Justin Van Meeteren

9:30 AM – 9:50 AM                    AtriClip Recorded Case – Dr. Krzysztof Bartus

9:50 AM – 10:00 AM                    Post-Procedural Management of AtriClip – Pericarditis/Anticoagulation/Imaging - Dr. Basel Ramlawi

10:00 AM – 10:20 AM                 Lariat Recorded Case – Dr. Randall Lee

10:20 AM – 10:40 AM                WaveCrest Recorded Case – Dr. Andrea Natale

10:40 AM – 11:00 AM                Panel Discussion

Session IV Miscellaneous LAA Occlusion Devices

Chair – Dr. Jacqueline Saw                                

Discussants– Dr. Aloke Finn and Dr. Christopher Ellis

11:20 AM – 11:30 AM                Conforma LAA Occlusion Device - Dr. Vivek Reddy

11:30 AM – 11:40 AM                 WATCHMAN Trials Update – Dr. Saibal Kar

11:40 AM – 11:50 AM                 Amplatzer Cardiac Plug Trials Update – Amulet IDE & More - Dr. Dhanunjaya Lakkireddy

11:50 AM – 12:00 AM                AtriClip, LAAOS III, Convergent and More – Treating AF and LAA at the same time – Dr. Felix Yang

12:00 PM – 12:20 PM                Panel Discussion      

12:20 PM – 1:00 PM                   Lunch

Session X

Chair – Dr. Randall Lee                             

Discussants– Dr. Saibal Kar and Dr. Abdi Rasekh

1:00 PM – 1:10 PM                    What Other Data Does It Take for LAAO Indication Change from II A to I – Dr. Andrea Russo

1:10 PM – 1:20 PM                    WATCHMAN vs WATCHMAN FLX – What is Different and Better? – Dr. David Holmes

1:20 PM – 1:30 PM                    Feasibility and Safety of Same Day LAAO and TAVR/TMVR WATCHMAN-TAVR Study and More – Dr. Amar Krishnaswamy

1:30 PM – 1:40 PM                    Transitioning LAA Exclusion Technology from Clinical Trials to Market Place – Lessons From the Lariat, WATCHMAN and ACP Experience - Dr. Dhanunjaya Lakkireddy

1:40 PM – 1:50 PM                    How to Build A Successful LAA Referral Program – Dr. Vijay Swarup

1:50 PM – 2:00 PM                    Role of Left Atrial Appendage Closure in Valvular Heart Disease and Atrial Fibrillation – Dr. Ajay Naik

2:00 PM – 2:20 PM                    Panel Discussion

2:20 PM – 2:40 PM    Break

Session XI Oral Anticoagulants in 2017

Chair – Dr. David Thaler                            

Discussants – Dr. Yoaav Krauthammer and Dr. Carlos Sanchez

2:40 PM – 2:50 PM                    A Pathologist Perspective on The Future of Stroke Prophylaxis, LAA Occluders and Tissue Specific Targets – Dr. Aloke Finn

2:50 PM – 3:00 PM                    AF Ablation, LAAO – Sequentially or Simultaneously and Why? – Dr. Claudio Tondo

3:00 PM – 3:10 PM                    Understanding NOACs in the 21st Century – Dual/Triple Therapy and Balancing AF and CAD – Dr. Michael Ezekowitz

3:10 PM – 3:20 PM                    My Patient Has an LAA Occluder And Had an Embolic CVA With No Evidence of Device Related Thrombus or Carotid Disease – What Do I Do? – Dr. David Holmes

3:20 PM – 3:30 PM                    Safety of External Cardioversion in Patients with LAA Exclusion – What Do We Know? – Dr. Amin Al-Ahmad

3:30 PM – 3:40 PM                   Understanding LAA Closure Device Related Erosions, Pumonary Vein and Mitral Valve Impingement - Dr. Apostolos Tzikas

3:40 PM – 3:50 PM                    Should LAA Exclusion be Performed Routinely in Patients that are High Risk for AF During Open Heart Surgery? – Dr. James Edgerton

3:50 PM – 4:10 PM                    Panel Discussion

Session XII Clinical Case

Chair – Dr. David Holmes    

Discussants –  Dr. David Wilber and Dr. Dhanunjaya Lakkireddy

4:10 PM – 5:20 PM                  My Most Challenging Cases –

                                                Dr. Apostols Tzikas

                                                Dr. Yoaav Krauthammer

                                                Dr. Luigi Di Biase

 5:20 PM                                   Adjourn/Remarks

Session XIII

Chair – Dr. David Holmes Jr.                        

Discussant – Dr. Moussa Mansourand Dr. David Wilber

4:10 PM – 5:00 PM

My Most Challenging Cases

5:00 PM

Adjourn/Remarks

ISLAA 2019

Date

March 8-9, 2019
(Friday to Saturday)

Venue

The Westin Crown Center
1 East Pershing Rd., Kansas City, MO 64108